Artif Organs. 2021 Aug;45(8):E223-E303. doi: 10.1111/aor.13918. Epub 2021 Mar 04.

Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation.

Artificial organs

Michael R Boswell, John M Stulak, Vakhtang Tchantchaleishvili, Matthew P Weber, Matthew A Warner, Bradford B Smith, Mark M Smith

PMID: 33469913 DOI: 10.1111/aor.13918

Abstract

Prothrombin complex concentrate (PCC) administration has increased among cardiac surgery patients in recent years; however, use in LVAD implantation/exchange is not widespread due to the fear of thrombotic complications. The purpose of this study was to compare the clinical outcomes of patients undergoing LVAD implantation/exchange with intraoperative PCC administration versus traditional transfusion practices alone. Adult LVAD implants/exchanges at our institution between 2015 and 2018 were included. Patients were categorized as receiving intraoperative PCC or no-PCC (traditional). The primary outcome was the need for allogenic transfusion and transfusion volume at 48 hours after initial intensive care unit (ICU) admission. Secondary outcomes included metrics of morbidity and mortality. A total of 160 patients (39 PCC, 121 traditional) were analyzed. In unadjusted analysis, patients in the PCC group received lower intraoperative transfusion volumes compared to the traditional group although not statistically significant (1464 mL [IQR 796, 4876] vs. 2568 mL [IQR 1292, 3606]; P value .37). In the fully adjusted analysis, patients in the PCC group had increased odds of transfusion within 48 hours of ICU admission (OR 4.06, 95% CI: 1.35-12.20; P < .01); however, there was no significant difference in transfusion volumes (P = .09). Patients receiving PCCs had higher incidence of deep vein thrombosis (10.3% vs. 0%; P  < .01) and 30-day mortality (17.9% vs. 4.1%; P < .01). LVAD pump thrombosis occurred in 2.6% versus 0.8% in the PCC and traditional groups, respectively; P = .98. Patients undergoing LVAD implantation and exchange represent a complex surgical cohort. The results of this study suggest that the intraoperative PCC use during LVAD implant/exchange was associated with reduced intraoperative transfusions. Intraoperative PCC use was, however, associated with higher odds of postoperative transfusion, although transfusion volumes were not significantly different. While the deep vein thrombosis and 30-day mortality rates were higher in the PCC group, these results are likely related to the degree of surgical and patient complexity rather than PCC use itself. Further studies are needed to assess PCC use in this surgical cohort.

© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.

Keywords: left ventricular assist device; prothrombin complex concentrate; transfusion

References

1. Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646-59. - PubMed
2. Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant. 2007;7:2388-95. - PubMed
3. Rose E, Gelijns A, Moskowitz A, Heitjan D, Stevenson L, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43. - PubMed
4. Miller L, Pagani F, Russell S, John R, Boyle A, Aaronson K, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96. - PubMed
5. Sun GH, Patel V, Moreno-Duarte I, Zahedi F, Ursprung E, Couper G, et al. Intraoperative administration of 4-factor prothrombin complex concentrate reduces blood requirements in cardiac transplantation. J Cardiothorac Vasc Anesth. 2018;32:161-7. - PubMed
6. Konopka CI, Horn ET, Murali S, Benza RL, Moraca RJ, Bailey SH. Evaluation of prothrombin complex concentrate in Warfarin reversal prior to heart transplantation in patients with durable mechanical circulatory support. J Heart Lung Transplant. 2017;36:S150-1. - PubMed
7. Song HK, Tibayan FA, Kahl EA, Sera VA, Slater MS, Deloughery TG, et al. Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery. J Thorac Cardiovasc Surg. 2014;147:1036-40. - PubMed
8. Tellor B, Shuster J, Human T, LaRue S, Vader J, Balsara K. Four-factor prothrombin complex concentrate for bleeding in patients with LVADs. J Heart Lung Transplant. 2017;36:63 - PubMed
9. Bradford CD, Stahovich MJ, Dembitsky WP, Adamson RM, Engelbert JJ, Perreiter AS. Safety of prothombin complex concentrate to control excess bleeding during continuous flow LVAD insertion. ASAIO J. 2015;61:509-15. - PubMed
10. Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, et al. Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. Crit Care. 2016;20:5. - PubMed
11. Demeyere R, Gillardin S, Arnout J, Strengers PF. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang. 2010;99:251-60. - PubMed
12. Fitzgerald J, Lenihan M, Callum J, et al. Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: a propensity score matched comparison to plasma. Br J Anaesth. 2018;120:928-34. - PubMed
13. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011;51:338-43. - PubMed
14. Milling TJ Jr, Refaai MA, Sarode R, Lewis B, Mangione A, Durn BL, et al. Safety of a Four-factor prothrombin complex concentrate versus plasma for vitamin K antagonist reversal: an integrated analysis of two phase IIIb clinical trials. Acad Emerg Med. 2016;23:466-75. - PubMed
15. Slaughter M, Rogers J, Milano C, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-51. - PubMed
16. Takatani S. Progress of rotary blood pumps: presidential address, international society for rotary blood pumps. Artif Organs. 2007;31:329-44. - PubMed
17. Argiriou M, Kolokotron SM, Sakellaridis T, Argiriou O, Charitos C, Zarogoulidis P, et al. Right heart failure post left ventricular assist device implantation. J Thorac Dis. 2014;6 Suppl 1:S52-9. - PubMed
18. Sabashnikov A, Mohite PN, Zych B, García D, Popov A-F, Weymann A, et al. Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation. ASAIO J. 2014;60:162-9. - PubMed
19. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773-81; discussion 5A-6A. - PubMed
20. Fida N, Loebe M, Estep J, Guha A. Predictors and management of right heart failure after left ventricular assist device implantation. Methodist DeBakey Cardiovasc J. 2015;11:18-23. - PubMed
21. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27:1065-72. - PubMed
22. Society of Thoracic Surgeons Blood Conservation Guideline Task F, Ferraris VA, Brown JR, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944-82. - PubMed
23. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e152S-e84S. - PubMed
24. Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost. 2016;116:879-90. - PubMed
25. Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, et al. Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. Ann Thorac Surg. 2019;107:1275-83. - PubMed
26. AABB. Circular of information for the use of human blood and blood components. 2017. - PubMed
27. Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The society of thoracic surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships. Ann Thorac Surg. 2019;107:341-53. - PubMed
28. Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, et al. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant. 2011;30:888-95. - PubMed
29. Dang NC, Topkara VK, Mercando M, Kay J, Kruger K, Aboodi M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1-6. - PubMed
30. Kukucka M, Potapov E, Stepanenko A, Weller K, Mladenow A, Kuppe H, et al. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg. 2011;141:1009-14. - PubMed
31. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163-72. - PubMed
32. Fida N, Loebe M, Estep J, Guha A. Predictors and management of right heart failure after left ventricular assist device implantation. Houston Methodist DeBakey Cardiovasc J. 2015;11:18-23. - PubMed
33. Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26:217-29. - PubMed
34. Fitzpatrick JR 3rd, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED, et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009;137:971-7. - PubMed
35. Tchantchaleishvili V, Maltais S, Sharma S, Haglund NA, Davis ME, Cowger J, et al. A novel, highly discriminatory risk model predicting acute severe right ventricular failure in patients undergoing continuous-flow left ventricular assist device implant. Artif Organs. 2019;43:624-32. - PubMed
36. Holman WL. Interagency Registry for mechanically assisted circulatory support (INTERMACS): what have we learned and what will we learn? Circulation. 2012;126:1401-6. - PubMed
37. Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant. 2015;34:1123-30. - PubMed

Publication Types

• Journal Article